BREAKING
Helmerich & Payne Jumps 5.3% After Morgan Stanley Maintains Underweight 3 hours ago TransDigm Group Drops 5.8% Amid Sector-Wide Selling 4 hours ago Why Pegasystems Is Dropping 6.0%: DA Davidson Maintains Buy 5 hours ago United Community Banks Delivers 12% Revenue Growth in Q1 2026 5 hours ago Why Fmc Is Dropping 6.8%: Wells Fargo Maintains Equal-Weight 5 hours ago Alpha Metallurgical Resources Jumps 5.9% Amid Sector-Wide Rally 5 hours ago Why Tractor Supply Is Dropping 11%: Baird Maintains Outperform 6 hours ago Brinker International Drops 8.2% After TD Cowen Maintains Buy 6 hours ago Why Calix Is Dropping 3.2%: JP Morgan Maintains Overweight 6 hours ago NetApp Jumps 5.5% Amid Sector-Wide Rally 6 hours ago Helmerich & Payne Jumps 5.3% After Morgan Stanley Maintains Underweight 3 hours ago TransDigm Group Drops 5.8% Amid Sector-Wide Selling 4 hours ago Why Pegasystems Is Dropping 6.0%: DA Davidson Maintains Buy 5 hours ago United Community Banks Delivers 12% Revenue Growth in Q1 2026 5 hours ago Why Fmc Is Dropping 6.8%: Wells Fargo Maintains Equal-Weight 5 hours ago Alpha Metallurgical Resources Jumps 5.9% Amid Sector-Wide Rally 5 hours ago Why Tractor Supply Is Dropping 11%: Baird Maintains Outperform 6 hours ago Brinker International Drops 8.2% After TD Cowen Maintains Buy 6 hours ago Why Calix Is Dropping 3.2%: JP Morgan Maintains Overweight 6 hours ago NetApp Jumps 5.5% Amid Sector-Wide Rally 6 hours ago
ADVERTISEMENT
REGN

Regeneron Pharmaceuticals Inc

$REGN NASDAQ May 6, 2021 DMH Q1 2021

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

REGN Coverage

Event Regeneron Pharmaceuticals Inc (REGN) Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial Apr 21, 2026 Event Regeneron Pharmaceuticals Inc (REGN) Goldman Sachs 47th Annual Global Healthcare Conference Apr 20, 2026 Event Regeneron Pharmaceuticals Inc (REGN) BofA Securities Health Care Conference 2026 Apr 20, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Transcript Feb 2, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7% May 4, 2023 Press Release Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31% Feb 3, 2023